CRP and neurodegenerative disease: Pentameric C-reactive protein (CRP/hsCRP) and its counterpart interleukin-6 (IL-6 are key acute-phase reactants recognized as biomarkers and potential mediators at the interface between systemic autoimmune inflammation and neurodegenerative disease, particularly Alzheimer’s disease (AD).